长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00775 长江生命科技

交易中 05-15 10:31:33

0.730

+0.010

+1.39%

最高0.730	最低0.720	成交量31.20万
今开0.730	昨收0.720	日振幅1.39%
总市值70.16亿	流通市值70.16亿	总股本96.11亿
成交额22.69万	换手率0.00%	流通股本96.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00775","market":"HK","secType":"STK","nameCN":"长江生命科技","latestPrice":0.73,"timestamp":1778812206543,"preClose":0.72,"halted":0,"volume":312000,"delay":0,"changeRate":0.013888888888888902,"floatShares":9611072400,"shares":9611072400,"eps":-0.0194,"marketStatus":"交易中","change":0.01,"latestTime":"05-15 10:31:33","open":0.73,"high":0.73,"low":0.72,"amount":226880,"amplitude":0.013889,"askPrice":0.73,"askSize":618000,"bidPrice":0.72,"bidSize":844000,"shortable":3,"etf":0,"ttmEps":-0.0194,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1778817600000},"marketStatusCode":2,"adr":0,"listingDate":1026748800000,"exchange":"SEHK","adjPreClose":0.72,"openAndCloseTimeList":[[1778808600000,1778817600000],[1778821200000,1778832000000]],"volumeRatio":0.638513,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00775/tweets","defaultTab":"tweets","newsList":[{"id":"1199724940","title":"长江生命科技高层变动：李源辞任执行董事、副总裁兼首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1199724940","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199724940?lang=zh_cn&edition=full","pubTime":"2026-05-08 21:38","pubTimestamp":1778247493,"startTime":"0","endTime":"0","summary":"长江生命科技国际有限公司宣布，李源（Lance Richard Lee Yuen）已辞去公司执行董事、副总裁及首席执行官职务。此次人事变动即刻生效，标志着公司管理层迎来重要调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1569","00775","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633454462","title":"长江生命科技(00775)：Lance Richard Lee Yuen辞任执行董事、副总裁及行政总监","url":"https://stock-news.laohu8.com/highlight/detail?id=2633454462","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633454462?lang=zh_cn&edition=full","pubTime":"2026-05-08 21:38","pubTimestamp":1778247492,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技(00775)公布，Lance Richard Lee Yuen先生自2026年5月8日起辞任公司执行董事、副总裁及行政总监，惟将继续担任公司加拿大附属公司的董事，负责监督当地业务。此外，执行董事余英才先生自2026年5月8日起，由现任公司副主席调任为副主席及行政总监。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1569","BK1161","00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157997333","title":"长江生命科技2026年4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1157997333","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157997333?lang=zh_cn&edition=full","pubTime":"2026-05-05 17:06","pubTimestamp":1777971994,"startTime":"0","endTime":"0","summary":"长江生命科技（股票代码：00775）近日发布截至2026年4月30日止的月报表并于2026年5月5日提交。公告显示，公司法定注册股本数目为15,000,000,000股，每股面值为0.1港元，合计注册股本金约15亿港元，较上月无变化。\n公司已发行股份数目期末余额为9,611,072,400股，无库存股份，与上月保持一致。报告期内，公司并未进行任何股份发行、购回或注销，也无股份期权、权证及可换股票据的授出或行使，股本结构整体维持稳定。\n公司确认，截至2026年4月30日，符合香港联交所相关上市规则关于公众持股量的要求。本次公告由公司秘书杨逸芝于2026年5月5日签署并提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8d4c202617d87be1d9fe31f833a300a8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148808097","title":"长江生命科技2025年度：科研投入加大，多元业务结构呈现新变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1148808097","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148808097?lang=zh_cn&edition=full","pubTime":"2026-04-17 16:45","pubTimestamp":1776415559,"startTime":"0","endTime":"0","summary":"长江生命科技于报告期内整体业绩由盈转亏，年度亏损约1.88亿元，而上年度亏损约1.27亿元。公司方面指出，受全球经济复苏节奏、研发支出增加及市场竞争等多重因素影响，报告期利润水平出现显著下滑，不过综合全面收益则因资产重估及汇兑因素而实现一定回升。在主营生命科技与医药研发板块，公司年内持续推动针对RNA疗法、免疫疗法及神经性疼痛等领域的管线项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130216431","title":"长江生命科技拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1130216431","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130216431?lang=zh_cn&edition=full","pubTime":"2026-04-17 16:41","pubTimestamp":1776415283,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于近日在公告中披露，董事会将于2026年5月21日举行股东周年大会，以寻求授权回购不超过公司当日已发行股份总数10%的股份。根据公告，长江生命科技过去十二个月股价最高曾达每股1.10港元，最低曾见每股0.45港元。公告同时提及，股东周年大会预计于5月21日上午9时在香港及网上进行，并将就上述授权进行表决。董事会声明，此举符合公司及全体股东的整体最佳利益。该计划最终能否落实尚需获得股东大会的批准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172273721","title":"长江生命科技3月无新增发行或股份变动，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1172273721","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172273721?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:40","pubTimestamp":1775126444,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于2026年4月2日公布截至2026年3月31日的月度股份变动情况。报告期内，公司法定股本维持在15,000,000,000股普通股，面值每股港币0.1元，法定股本总额为港币1,500,000,000元。已发行股份数量与上月底相比无变化，仍为9,611,072,400股，库存股份数量为零。长江生命科技集团有限公司在公告中确认，其截至2026年3月31日符合香港联交所对最低公众持股量的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189053459","title":"长江生命科技旗下Sequencio Therapeutics在美国癌症研究协会年会展示疫苗研究最新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1189053459","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189053459?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:16","pubTimestamp":1774952199,"startTime":"0","endTime":"0","summary":"长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。\n此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775","BK1569","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623302237","title":"长江生命科技(00775)附属顺谱医药科技将在AACR 2026年会上展示治疗性癌症疫苗研发系列的研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2623302237","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623302237?lang=zh_cn&edition=full","pubTime":"2026-03-31 17:17","pubTimestamp":1774948639,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技 发布公告，公司附属公司顺谱医药科技有限公司将在美国圣地牙哥举行的美国癌症研究协会2026 年度年会上，展示治疗性癌症疫苗研发系列的研究数据。此乃顺谱医药科技自成立以来发表的首个重要科研成果，展示以专有 TrueHLA Epitope-to-Efficacy转化设计框架，研究新一代癌症疫苗技术取得的重大进展。在发表中展示的该等数据充分印证顺谱医药科技从抗原筛选转化至功能性免疫反应及肿瘤控制上的优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1569","159938","09939","00775","BK1515","159646","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620783360","title":"港股异动 | 长江生命科技(00775)再跌超4% 研发开支显著增长 全年亏损扩至1.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620783360","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620783360?lang=zh_cn&edition=full","pubTime":"2026-03-20 15:12","pubTimestamp":1773990758,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长江生命科技(00775)再跌超4%，月内累计跌幅近15%。截至发稿，跌4%，报0.72港元，成交额592.62万港元。消息面上，长江生命科技发布年度业绩，该集团取得收入54.1亿港元，同比减少2%；公司股东权益应占亏损1.87亿港元，同比增加47.61%。公告称，2025年度的股东应占亏损较2024年度增加6020万港元，当中反映研发开支增加6650万港元，以及数项非现金的特殊项目及一次性项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1569","00775","BK4588","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620252344","title":"长江生命科技(00775)发布年度业绩，股东应占亏损1.87亿港元 同比增加47.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620252344","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620252344?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:45","pubTimestamp":1773744312,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技(00775)发布2025年度业绩，该集团取得收入54.1亿港元，同比减少2%;公司股东权益应占亏损1.87亿港元，同比增加47.61%;每股亏损1.94港仙。2025年度的股东应占亏损较2024年度增加6020万港元，当中反映研发开支增加6650万港元，以及数项非现金的特殊项目及一次性项目，包括葡萄园资产组合估值取得较大跌幅、数项拨备，以及有关从事研发的附属公司 Polynoma与纳斯达克上市公司TransCode Therapeutics( NAZ) 的交易收益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"长江生命科技(00775)发布年度业绩，股东应占亏损1.87亿港元 同比增加47.61%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00775","BK1569","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618979653","title":"每日卖空追踪 | 长江生命科技 03月11日卖空量成交102.6万股，卖空比例为10.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618979653?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217816,"startTime":"0","endTime":"0","summary":"长江生命科技北京时间03月11日，涨2.56%，卖空量成交102.6万股，较上一交易日增加180.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163125a6b792c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163125a6b792c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1569","00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618796639","title":"长江生命科技03月11日主力净流入108.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618796639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618796639?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:15","pubTimestamp":1773216954,"startTime":"0","endTime":"0","summary":"03月11日, 长江生命科技股价涨2.56%，报收0.80元，成交金额783.3万元，换手率0.10%，振幅3.85%，量比1.27。长江生命科技今日主力资金净流入108.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨1.27%，主力资金累计净流出109.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2048.7万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162027a6b789bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162027a6b789bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00775","BK1569"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113928693","title":"长江生命科技成立Sequencio Therapeutics，加速推进治疗性癌症疫苗研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1113928693","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113928693?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:48","pubTimestamp":1773143327,"startTime":"0","endTime":"0","summary":"长江生命科技（股份代号：00775）近日宣布成立Sequencio Therapeutics公司，致力于推动治疗性癌症疫苗的研发进程。该举措标志着公司在生物科技领域迈出重要一步，旨在通过创新疗法为癌症治疗提供新方案。\nSequencio Therapeutics将专注于利用先进技术平台开发靶向性肿瘤疫苗，探索个体化免疫治疗路径。此次战略布局有望强化长江生命科技在肿瘤治疗领域的技术储备，并为长期发展注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775","BK1161","BK1569"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618474938","title":"长江生命科技(00775)宣布成立顺谱医药科技有限公司 专注推动旗下治疗性癌症疫苗组合的发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2618474938","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618474938?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:57","pubTimestamp":1773133025,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技 发布公告，宣布成立公司全资附属公司顺谱医药科技有限公司，专注推动旗下治疗性癌症疫苗组合的发展。公司成立 Sequencio，将旗下治疗性癌症疫苗研发项目整合至一个专注平台，充分体现公司锐意拓展此新兴癌症免疫疗法领域的策略方针。Sequencio 肩负长远愿景——重塑癌症治疗模式，从引导短暂性肿瘤缩小，迈向透过免疫系统达致长期可控的缓解。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","BK1574","00775","BK1515","159938","09939","BK1569","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618936986","title":"每日卖空追踪 | 长江生命科技 03月10日卖空量成交31万股，卖空比例为12.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618936986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618936986?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:30","pubTimestamp":1773131415,"startTime":"0","endTime":"0","summary":"长江生命科技北京时间03月10日，涨1.3%，卖空量成交31万股，较上一交易日减少89.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163126a45df59b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163126a45df59b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00775","BK1569","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617454314","title":"长江生命科技(00775.HK)拟3月17日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2617454314","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617454314?lang=zh_cn&edition=full","pubTime":"2026-03-05 18:27","pubTimestamp":1772706424,"startTime":"0","endTime":"0","summary":"格隆汇3月5日丨长江生命科技(00775.HK)宣布，公司将于2026年3月17日(星期二)于香港举行董事会会议，以(其中包括)批准刊发公司及其附属公司截至2025年12月31日止财政年度之业绩，以及考虑派发末期股息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260305/32047477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00775","BK1569","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617590538","title":"每日卖空追踪 | 长江生命科技 03月04日卖空量成交157.8万股，卖空比例为15.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617590538","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617590538?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613015,"startTime":"0","endTime":"0","summary":"长江生命科技北京时间03月04日，跌1.25%，卖空量成交157.8万股，较上一交易日增加41.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163142a6a14b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163142a6a14b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00775","BK1161","BK1569"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617591363","title":"长江生命科技03月04日遭主力抛售29.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617591363","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617591363?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612153,"startTime":"0","endTime":"0","summary":"03月04日, 长江生命科技股价跌1.25%，报收0.79元，成交金额787.7万元，换手率0.10%，振幅3.75%，量比0.30。长江生命科技今日主力资金净流出29.5万元，连续5日净流出，上一交易日主力净流出157.9万元。该股近5个交易日下跌8.14%，主力资金累计净流出521.6万元；近20日主力资金累计净流入1728.4万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304162003a6a13f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304162003a6a13f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1569","00775","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195054319","title":"长江生命科技（00775）2026年2月股份维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1195054319","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195054319?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:58","pubTimestamp":1772528308,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于2026年3月3日发布2026年2月股份变动月报表。公告显示，截至报告期末，公司股本结构与上月相比维持稳定，未发生新增发行、购回或注销股份的情况。截至本月底，已发行普通股数量为9,611,072,400股，库藏股数量为0股，与上月底保持一致。基于公司董事可获公开资料以及董事所知悉信息，长江生命科技确认符合香港联交所股份最少公众持股量的相关规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616634883","title":"每日卖空追踪 | 长江生命科技 03月02日卖空量成交57.2万股，卖空比例为4.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616634883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616634883?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440217,"startTime":"0","endTime":"0","summary":"长江生命科技北京时间03月02日，跌3.57%，卖空量成交57.2万股，较上一交易日减少96.72%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163207a730c3c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163207a730c3c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00775","BK1569"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ck-lifesciences.com","stockEarnings":[{"period":"1week","weight":-0.04},{"period":"1month","weight":-0.0137},{"period":"3month","weight":-0.1429},{"period":"6month","weight":-0.191},{"period":"1year","weight":-0.1325},{"period":"ytd","weight":-0.122}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":0.02},{"period":"3month","weight":-0.0067},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1163},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长江生命科技集团有限公司是一家主要从事健康产品研发及销售业务的投资控股公司。该公司主要从事保健产品及医药产品的研发、生产、推广及销售等人类健康业务。该公司旗下保健产品品牌包括Lipa，Vitaquest以及Sante Naturelle等。其研发药物产品主要包括癌症相关药物及止痛药物等。农业相关业务分部经营葡萄园以及研发、生产、推广及销售农业及相关产品。其农业产品包括肥料产品及植物保护产品等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.015869},{"month":2,"riseRate":0.458333,"avgChangeRate":0.029716},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.079623},{"month":4,"riseRate":0.625,"avgChangeRate":0.06428},{"month":5,"riseRate":0.416667,"avgChangeRate":0.016146},{"month":6,"riseRate":0.391304,"avgChangeRate":-0.010794},{"month":7,"riseRate":0.521739,"avgChangeRate":0.015068},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.018217},{"month":9,"riseRate":0.25,"avgChangeRate":-0.022361},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.019483},{"month":11,"riseRate":0.5,"avgChangeRate":0.061425},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.0026}],"exchange":"SEHK","name":"长江生命科技","nameEN":"CKLIFE SCIENCES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长江生命科技(00775)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长江生命科技,00775,长江生命科技股票,长江生命科技股票老虎,长江生命科技股票老虎国际,长江生命科技行情,长江生命科技股票行情,长江生命科技股价,长江生命科技股市,长江生命科技股票价格,长江生命科技股票交易,长江生命科技股票购买,长江生命科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长江生命科技(00775)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}